Sign In
Buy SENS
$5.29
-0.0900 (-1.67%)
At Close: Jul 13, 2026
Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?
06:56am, Monday, 29'th Jun 2026
Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership
02:11pm, Thursday, 11'th Jun 2026
SENS partners with Welldoc on a next-gen Eversense 365 app, adding Apple Health/Google Health Connect integration ahead of the U.S. launch.
Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM's differentiated approach and high performance
Senseonics Holdings, Inc. (SENS) Shareholder/Analyst Call Transcript
03:22pm, Saturday, 06'th Jun 2026
Senseonics Holdings, Inc. (SENS) Shareholder/Analyst Call Transcript
Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026
08:00am, Monday, 01'st Jun 2026
GERMANTOWN, Md., June 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term,
Senseonics Holdings, Inc. Common Stock Q1 Earnings Call Highlights
09:07pm, Friday, 08'th May 2026
Senseonics Holdings, Inc. Common Stock NASDAQ: SENS raised its full-year 2026 revenue outlook after reporting first-quarter growth tied to adoption of its Eversense 365 continuous glucose monitoring s
Senseonics Holdings, Inc. (SENS) Q1 2026 Earnings Call Transcript
01:21pm, Friday, 08'th May 2026
Senseonics Holdings, Inc. (SENS) Q1 2026 Earnings Call Transcript
Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue Estimates
07:01pm, Thursday, 07'th May 2026
Senseonics Holdings (SENS) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to a loss of $0.4 per share a year ago.
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
04:01pm, Thursday, 07'th May 2026
Generated Q1 revenue of $11.7 million, an increase of 87% year-over-year Expect full-year revenue in the range of $60M - $64M (previously $58M to $62M) Strong strategic and commercial progress, includ
GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the design, development and commercialization of long-term, implanta
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million
08:00am, Monday, 04'th May 2026
GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring p
Senseonics Shares Sink Friday: What's Driving The Move?
10:06am, Friday, 01'st May 2026
Shares of Senseonics Holdings Inc (NASDAQ:SENS) are trading sharply lower Friday morning following the late-Thursday announcement of the pricing for an $80 million underwritten public offering. Here's
GERMANTOWN, Md., May 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development, manufacturing and commercialization of long-term, im
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
09:50pm, Thursday, 30'th Apr 2026
GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term,
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
04:01pm, Thursday, 30'th Apr 2026
GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term,
